Pfizer Pharmacokinetic Test Document

Paul Jones made this Official Information request to Ministry of Health

The request was partially successful.

From: Paul Jones

Dear Ministry of Health,

Concerning a Pfizer Confidential document with page title "SARS-COV-2 mRNA Vaccine (BNT162, PF-07302048)" section name "2.6.4 Overview of Pharmacokinetic Test".

A leaked version of this document is available here https://files.catbox.moe/0vwcmj.pdf for clarity.

Please inform the date this document was received by the Ministry of Health or other departments (eg: Medsafe)?

Yours faithfully,

Paul Jones

Link to this

From: OIA Requests

Kia ora Paul,

 

Thank you for your request for official information received on 16^th June
2021 for:

 

"Dear Ministry of Health,

 

Concerning a Pfizer Confidential document with page title "SARS-COV-2 mRNA
Vaccine (BNT162, PF-07302048)" section name "2.6.4 Overview of
Pharmacokinetic Test".

 

A leaked version of this document is available here
[1]https://scanmail.trustwave.com/?c=15517&...
for clarity.

 

Please inform the date this document was received by the Ministry of
Health or other departments (eg: Medsafe)?

 

Yours faithfully,

 

Paul Jones"

 

The Ministry's reference number for your request is: H202107252

 

As required under the Official Information Act 1982, the Ministry will
endeavour to respond to your request no later than 14^th July 2021, being
20 working days after the day your request was received.

 

If we are unable to respond to your request within this time frame, we
will notify you of an extension of that time frame.

 

If you have any queries related to this request, please do not hesitate to
get in touch.

 

Ngā mihi,

 

OIA Services

Government Services

Office of the Director-General

Ministry of Health

E: [2][email address]

 

-----Original Message-----
From: Paul Jones <[FOI #15806 email]>
Sent: Wednesday, 16 June 2021 1:18 pm
To: OIA Requests <[email address]>
Subject: Official Information request - Pfizer Pharmacokinetic Test
Document

 

Dear Ministry of Health,

 

Concerning a Pfizer Confidential document with page title "SARS-COV-2 mRNA
Vaccine (BNT162, PF-07302048)" section name "2.6.4 Overview of
Pharmacokinetic Test".

 

A leaked version of this document is available here
[3]https://scanmail.trustwave.com/?c=15517&...
for clarity.

 

Please inform the date this document was received by the Ministry of
Health or other departments (eg: Medsafe)?

 

Yours faithfully,

 

Paul Jones

 

-------------------------------------------------------------------

 

This is an Official Information request made via the FYI website.

 

Please use this email address for all replies to this request:

[4][FOI #15806 email]

 

Is [5][Ministry of Health request email] the wrong address for Official Information
requests to Ministry of Health? If so, please contact us using this form:

[6]https://scanmail.trustwave.com/?c=15517&...

 

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[7]https://scanmail.trustwave.com/?c=15517&...

 

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

 

 

-------------------------------------------------------------------

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. https://scanmail.trustwave.com/?c=15517&...
2. mailto:[email address]
3. https://scanmail.trustwave.com/?c=15517&...
4. mailto:[FOI #15806 email]
5. mailto:[Ministry of Health request email]
6. https://scanmail.trustwave.com/?c=15517&...
7. https://scanmail.trustwave.com/?c=15517&...

hide quoted sections

Link to this

From: Paul Jones

Dear OIA Requests,

Please note that as the source document referenced was in Japanese the exact Pfizer documentation name original listed "SARS-COV-2 mRNA Vaccine (BNT162, PF-07302048)" could differ from similar materials provided to the NZ government.

Therefore would you please update this request to be; The date the NZ government and its departments received Pharmacokinetic test/study data from Pfizer for the Comirnaty BNT162* vaccine similar to the referenced study.

Yours sincerely,

Paul Jones

Link to this

victor left an annotation ()

Summary of reported deaths

Up to and including 22 May 2021, a total of 4 deaths were reported to CARM after the administration of the Comirnaty vaccine. CARM and Medsafe have assessed each of these cases and found that the deaths were unlikely to be caused by the vaccine.

By chance, some people will experience new illnesses or die from a pre-existing condition shortly after vaccination, especially if they are elderly.

Therefore, part of our review process includes comparing natural death rates to observed death rates following vaccination, to determine if there are any specific trends or patterns that might indicate a vaccine safety concern.

There are currently no indications to suggest that the vaccine caused the deaths.

- highly problematic at face value.

Link to this

Paul Jones left an annotation ()

We note in an updated Datasheet version here https://www.medsafe.govt.nz/profs/Datash...

It now has a Section 5.2 Pharmacokinetic properties saying its "Not Applicable".

Totally crazy for the persons in government involved to have such a position.

Link to this

From: OIA Requests


Attachment image001.gif
7K Download

Attachment H202107252 P.Jones Response.pdf
169K Download View as HTML


Kia ora Paul,

 

On behalf of Chris James, Group Manager, Medsafe, please see attached the
response to your OIA request.

 

Ngā mihi

OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [1][email address]

 

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. mailto:[email address]

hide quoted sections

Link to this

From: Paul Jones

Dear OIA Requests,

Thank you for your reply, however we made an update on 21st June refining our request to be;

"The date the NZ government and its departments received Pharmacokinetic test/study data from Pfizer for the Comirnaty BNT162* vaccine similar to the referenced study."

Therefore would you update your response accordingly.

Yours sincerely,

Paul Jones

Link to this

From: OIA Requests


Attachment image001.gif
7K Download

Attachment H202107252 P.Jones Response.pdf
173K Download View as HTML


Dear Paul,

 

On behalf of Chris James, Group Manager Medsafe, please see attached the
response to your OIA request.

 

 

 

Kind regards,

OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [1][email address]

 

 

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

--------------------------------------------------------------------------

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. mailto:[email address]

hide quoted sections

Link to this

Virginia Crawford left an annotation ()

The Ministry cannot supply this information because pharmacokinetics, as well as pharmacodynamics, genetics and biomarkers, were not evaluated. The Ministry is well aware of this.

Link to this

Things to do with this request

Anyone:
Ministry of Health only: